Literature DB >> 2861421

Antibiotic prophylaxis for coronary artery bypass graft surgery.

A R Penketh, M H Wansbrough-Jones, E Wright, F Imrie, J R Pepper, D J Parker.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 2861421     DOI： 10.1016/s0140-6736(85)92267-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  The effect of thorough preoperative disinfection on the incidence of postoperative mediastinitis.

Authors:  H Inaba; T Miyairi; T Ohbuchi; K Tanaka
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Antibiotic prophylaxis in cardiothoracic surgery in the United Kingdom: current practice.

Authors:  A P Wilson; T Treasure; M F Sturridge; R N Grüneberg
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

3.  Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery.

Authors:  Loren G Miller; James A McKinnell; Michael E Vollmer; Brad Spellberg
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

4.  Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients.

Authors:  A B Kaiser; M R Petracek; J W Lea; D S Kernodle; A C Roach; W C Alford; G R Burrus; D M Glassford; C S Thomas; W S Stoney
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

5.  Cefuroxime prophylaxis in cardiovascular surgery: clinical, microbiological, and ecological impact.

Authors:  L O Gentry; S M Birovljev; B Radovancević; D A Cooley
Journal:  Tex Heart Inst J       Date:  1992

6.  Prospective randomised comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting.

Authors:  S M Nooyen; B P Overbeek; A Brutel de la Rivière; A J Storm; J J Langemeyer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

7.  Editorial commentary: prophylaxis for surgical site infections.

Authors:  M Moghadami
Journal:  Iran Red Crescent Med J       Date:  2011-04-01       Impact factor: 0.611

8.  Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery.

Authors:  G Zanetti; S J Goldie; R Platt
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.